Li Ning Company: 11 Times Trailing Earnings and Almost RMB20 Billion of Net Cash, Against a Q2 2026 Sell-Through Reversal

The premiumisation evidence is weaker than the marketing narrative. Li Ning combines China Li-Ning and LI-NING 1990 with the core Li-Ning brand in its operating disclosures; it does not publicly provide a separate LI-NING 1990 revenue line, gross margin, average selling price, store-level return on capital or consistent stand-alone store-productivity series. The FY2025 presentation reports average monthly store productivity of approximately RMB284,000 for the relevant aggregate store base, versus RMB300,000 in the H1 2025 presentation. Because those are aggregate figures, they cannot establish that LI-NING 1990 itself is productive enough to justify the brand-elevation thesis. The premium line may be helping halo effects, but public disclosure does not let an outside investor prove it.

That disclosure gap matters more when compared with Anta. Anta generated more than RMB80.2bn of FY2025 revenue, up 13.3%, versus Li Ning's RMB29.6bn and 3.2%; FILA alone generated RMB28.47bn, almost the size of the entire Li Ning group. In Q2 2026 Anta and FILA retail sales still grew by low-single-digit percentages while Anta's other brands grew around 25–30%, against Li Ning's low-single-digit overall decline. Amer Sports grew revenue 27% in 2025, and Anta remained its controlling shareholder with an approximately 42% equity stake as of February 2026, lower than the 44.5% figure in the research brief. Anta also agreed in 2026 to acquire 29.06% of Puma. The portfolio advantage has therefore widened rather than narrowed.

The comparison does not mean multi-brand ownership is automatically superior. Anta bears M&A, integration and capital-allocation risk that Li Ning does not. Li Ning has an extraordinarily liquid balance sheet: cash and time deposits were approximately RMB19.97bn at FY2025, with no borrowings in the company's headline financial highlights. Against an equity market value of roughly RMB32.3bn after converting the 2026-08-07 market capitalisation at the stated FX rate, cash and deposits represent more than 60% of equity value. That is a large cushion against financial distress. It is also an implicit criticism of capital productivity: ROE has declined from 26.9% in the exceptional 2021 year to 10.9% in 2025 while cash accumulated.

Cash generation remains better than the earnings decline suggests. FY2025 operating cash flow was RMB4.852bn, 1.65 times reported net income, and reported capex was RMB1.293bn, leaving a simple OCF-minus-capex proxy of about RMB3.56bn. At the current RMB-equivalent equity value, that is around an 11% cash yield before adjusting for the economic treatment of leases. Across 2021–2025, aggregate operating cash flow was about 1.47 times aggregate net income. That reduces the probability that recent earnings were produced by weak cash conversion. It does not eliminate the operating problem: free cash flow is healthy because the business remains profitable and capital-light; it does not tell us that sales momentum is healthy.

Capital markets have already punished the distinction. The shares closed at HK$14.54 on 2026-08-07 and are near the bottom of a recent 52-week range of roughly HK$14.21–23.42. Using the HK$18.66 end-2025 share price disclosed in public filings as a starting point, the stock has fallen roughly 22% in 2026. Yet FY2025 EPS declined only 2.6%. The price decline therefore cannot be explained by the reported FY2025 earnings change alone. A large part represents forward-estimate reduction and multiple compression as the market moved from hopes of reacceleration after Q1 to renewed concern after Q2. July research updates show target-price reductions by several brokers, including Daiwa, BOCI and UOB Kay Hian.

This is partly a China-consumer problem. Nike has suffered a prolonged Greater China downturn, including multiple consecutive quarters of falling sales; Xtep's core brand also weakened in Q2 2026. But the “weak Chinese consumer explains everything” interpretation fails because Anta's portfolio is still growing, Adidas has rebuilt growth through more localised product, and newer running brands such as On and Hoka have expanded rapidly in China. Li Ning therefore faces both a cyclical demand problem and a company-specific execution/portfolio problem.

Portrait: company in transition. Li Ning is no longer the distressed turnaround of 2012–2015, and it is no longer the high-growth China-brand re-rating story of 2019–2021. It has become a cash-rich, mature domestic sports franchise trying to find a second act within one master brand. Running shows that product innovation can still create growth. The direct-store slowdown, fading gross margin, opaque premium-line economics and Anta's widening portfolio advantage show that the next growth curve has not yet been proven.

Vertical history and financial review

Li Ning's history matters because the same failure mode has appeared before: distributors can create apparent scale faster than end-consumer demand can absorb it.

The operating brand dates to around 1990 and grew around founder Li Ning's standing as one of China's best-known gymnasts. The listed vehicle is newer: Li Ning Company Limited was incorporated in the Cayman Islands on 2004-02-26 and listed on Hong Kong's Main Board on 2004-06-28. The IPO priced at HK$2.15 per share and raised roughly HK$530m. Shares finished their first trading day at HK$2.35, a 9.3% premium to the offer price. HKEX's 2004 Fact Book records the HK$2.15 offer and the 2004-06-28 listing.

The early listed-company model was overwhelmingly a distribution story. Li Ning owned the brand and product-development capability while franchisees provided much of the physical reach. By the end of 2008, the Li-Ning brand had 6,245 retail stores, an increase of 1,012 in a single year; about 95% of the network was franchised. The 2008 report also shows a broad investment in sport-specific R&D, including a dedicated sports-science centre and product technologies such as Li-Ning Bow. That combination of national brand recognition, aggressive store expansion, franchise capital and improving product was exactly suited to China's fast urbanisation and the surge in sport spending surrounding the Beijing Olympics.

The model overshot. By 2011 margins were under pressure from a new wholesale-discount policy, higher input costs and competition; the company warned that first-half profit margin could fall to 6–7% from 12.9% a year earlier. In 2012 bloated distributor inventories forced the company into a costly channel rescue. Reuters reported a plan involving as much as US$288m of expenses to buy back and clear inventory, while the company warned of a substantial annual loss. The eventual 2012 net loss was approximately RMB1.98bn.

That episode permanently changed how Li Ning should be analysed. Wholesale shipment growth is not sufficient evidence of brand health. Inventory age, distributor economics, retail sell-through and discount depth must be read together. The 2026 business is much healthier financially than the 2012 business, but the historical scar explains why the current combination of growing franchise revenue and declining franchise sell-through deserves attention.

The founder's return was the next decisive turn. After three consecutive annual losses, Li Ning returned to take direct operational leadership in 2015. The market reacted positively: the shares rose about 12% on the announcement, while the company was coming off a RMB781.5m 2014 loss. The turnaround did not come from financial engineering. The company reduced bad inventory, reworked its store and product system, embraced e-commerce and re-established a clearer connection between product creation and retail demand. Li Ning returned to profit in 2015, helped materially by rapid online growth.

That foundation met a powerful domestic-brand cycle after 2018. Product styling became more culturally distinctive, professional running and basketball received greater technology investment, online retail scaled, and China's consumer market became more receptive to domestic brands. By 2021 the financial transformation was dramatic: revenue reached RMB22.572bn, up 56.1%; attributable profit reached RMB4.011bn, up 136.1%; gross margin reached 53.0%; operating margin reached 22.8%; ROE reached 26.9%; and operating cash flow reached RMB6.525bn.

Capital markets priced that success aggressively. In late 2021 Li Ning issued 120m shares at HK$87.50 through a top-up placement, raising net proceeds of HK$10.433bn, or roughly RMB8.572bn. From the company's point of view, issuing equity at that valuation was excellent capital allocation: today's HK$14.54 share price is about 83% below the placement price. The more difficult question is what the company has achieved with the resulting capital. At the end of 2025 it still held nearly RMB20bn of cash and time deposits, and approximately RMB341m of the 2021 placement proceeds remained formally unutilised.

The post-2021 story is a long normalisation from exceptional profitability. The table below puts that reversal in context.

The 2021 figures come from the audited annual report; 2022–2024 are confirmed in subsequent company result releases, and 2025 from the audited annual results.

Revenue compounded by about 7.0% a year from 2021 to 2025, but attributable profit compounded down by about 7.5% a year. The margin line explains the divergence. The 53% gross margin and 17.8% net margin of 2021 were not a new permanent normal; the current economics are closer to a 49% gross margin and 10% net margin. Marketing investment has also risen: advertising and promotion reached 10.7% of FY2025 revenue versus 9.5% in 2024, while R&D was 2.4%. The brand is spending more to protect relevance while revenue growth slows.

There is still operating discipline. Selling and distribution expense fell marginally in absolute terms in 2025 even as revenue rose, taking the ratio to 31.0% from 32.1%; management achieved this by closing low-efficiency stores and reducing rental, labour and refurbishment costs. Administrative expense rose 14.2%, partly because of R&D talent and related costs. Thus the P&L contains two opposing forces: retail rationalisation is protecting operating profit, while the amount required to sustain brand/product competitiveness is rising.

The balance sheet is the strongest part of the investment case. Cash and equivalents were RMB16.717bn at end-2025, current and non-current time deposits added roughly RMB3.257bn, and the company reported no borrowings in its headline balance-sheet summary. Net cash/deposits were approximately RMB19.97bn, up from RMB18.16bn a year earlier. Lease liabilities remain economically real: about RMB2.06bn current plus non-current at FY2025. So “debt free” should not be interpreted as “no fixed financial commitments.”

Working capital is more nuanced.

Sources are Li Ning's FY2025 financial highlights and annual-results announcement; percentage changes are calculated from the reported figures.

The receivables increase is the item I would investigate hardest at the next full filing. Fifteen receivable days are not intrinsically alarming, and the bad-debt provision decreased slightly, but a 38% receivables increase when sales rose 3% is too large to dismiss. If it reflects timing, it should reverse. If it reflects easier terms to distributors as wholesale becomes a larger percentage of revenue, it would weaken the apparent quality of that channel growth.

Cash generation over five years is strong. Cumulative 2021–2025 operating cash flow was about 1.47 times cumulative net income. The simple FY2025 free-cash-flow proxy of operating cash flow minus reported capex was RMB3.56bn. Maintenance and growth capex are not separately disclosed, so an exact Buffett-style owner-earnings calculation is impossible. Treating all RMB1.293bn of 2025 capex as maintenance is deliberately conservative and gives the RMB3.56bn figure. It is roughly 21% above reported net profit, below the prompt's 30% threshold for abandoning accounting earnings entirely. IFRS 16 lease cash flows also mean OCF-minus-capex should not be read as unrestricted distributable cash. I therefore use both earnings and cash yield in valuation rather than mechanically capitalising the higher FCF number.

The long share-price history mirrors the operating stages. The HK$2.15 IPO became an Olympics-era growth story; the distribution excess of 2011–2012 destroyed that valuation narrative; the 2015 founder return created a turnaround trade; the 2018–2021 domestic-brand cycle produced a major growth re-rating and the HK$87.50 placement; since then the market has progressively moved Li Ning from “structural China growth” toward “mature consumer franchise.”

There was one striking interruption: Reuters reported in March 2024 that founder Li Ning was considering a take-private transaction with private-equity participation, and the shares rose as much as 20% on the report. As of 2026-08-08, I find no current privatisation offer or delisting process in the company's official announcement archive; the shares continue trading normally. Investors should therefore value the stock as a going-concern public equity, not assign speculative take-private value.

Business model, moat and industry cycle

Li Ning is often described as a “single-brand” company, but economically it is better thought of as one master consumer franchise distributed through several channels and extended into several sports.

FY2025 footwear generated RMB14.651bn, 49.5% of group revenue and 2.4% growth; apparel generated RMB12.327bn, 41.6% and 2.3% growth; equipment and accessories generated RMB2.621bn, 8.9% and 12.7% growth. The shift toward footwear is strategically helpful because performance footwear carries more technology, consumer repeat behaviour and product differentiation than generic sports apparel. It also raises the cost of staying technologically relevant.

Company-reported category and channel data.

The most important line is not footwear versus apparel; it is wholesale versus direct retail. Almost half of revenue now comes from distributors. That gives Li Ning greater asset efficiency and transfers store capex and part of the inventory burden to franchisees, but it weakens direct visibility into end-consumer demand. Direct retail gives better pricing control and access to retail gross profit, but it carries rent, labour and markdown risk. E-commerce is the fastest structurally scalable channel, yet online sporting goods in China are highly price-transparent and promotion-heavy.

That helps explain the FY2025 gross-margin movement. Revenue grew, but gross margin fell 40 basis points because direct retail became a smaller part of sales and promotions in company-operated stores intensified. Li Ning does not publish separate online, wholesale and direct-retail gross margins, so the precise online/offline margin gap requested in the brief cannot be calculated from public filings. Nor does it publish a clean same-store-sales series separately for franchise and direct stores. The closest recurring operating measures are retail sell-through, channel revenue, POS movement, store productivity, inventory months and new-product sell-through. Any report presenting exact channel gross margins or exact comparable-store growth without additional proprietary data would be inventing precision.

Running is currently the strongest evidence for a real product moat. Company-linked FY2025 operating material indicates running sell-through grew about 10% and accounted for roughly 31% of retail sell-through, up substantially from five years earlier. In H1 2025, more than 14m pairs of running shoes were sold across channels, with the Feidian, Chitu and Superlight franchises supplying a meaningful part of volume. This is the type of performance franchise that can survive beyond a fashion cycle: specialist runners care about weight, foam, plate geometry, durability and fit, while successful race products create credibility that can spill into mass-market running.

Basketball is more complicated. Li Ning has built real equity through long-term player and signature-shoe programmes, particularly the Way of Wade ecosystem, but FY2025 reporting indicates basketball lagged the stronger running and specialty categories. The 2026 partnership with Stephen Curry creates another potentially valuable global basketball asset, but its financial contribution is not yet established. The correct treatment today is catalyst, not earnings. The brand must show that basketball sell-through can improve without simply widening discounts.

The company's technology spending constitutes a modest but genuine moat component. R&D was about 2.4% of FY2025 sales and has supported proprietary cushioning, racing and lightweight-shoe platforms. The moat is not patents in the pharmaceutical sense; consumers can switch brands every purchase. It is the combination of accumulated footwear know-how, elite-athlete validation, design, supply-chain feedback and enough sales volume to amortise product-development spending.

Brand is the second moat. Li Ning has something most newer domestic competitors cannot manufacture quickly: more than three decades of association between a famous Chinese athlete and a national sporting-goods identity. That brand survived a near-catastrophic channel crisis and returned to growth after 2015. Survival across an adverse cycle is stronger evidence than a few years of social-media relevance.

Channel is the third moat, but it is a double-edged one. Thousands of stores provide physical reach far beyond China's biggest cities and support shoe fitting, launches and local club ecosystems. Yet the 2012 failure showed that a large distributor network becomes a liability when incentives reward sell-in rather than sell-through. The Q2 2026 combination of mid-single-digit franchise sell-through decline and continued net wholesale-store additions is therefore an indicator to watch carefully.

The weaker claimed moat is premiumisation. The company combines China Li-Ning and LI-NING 1990 with the broader Li-Ning brand in key operational disclosures, so public investors cannot observe the premium line's revenue, gross margin, average selling price, stock turn or return on store investment independently. This is central to the single-brand thesis. A premium extension can raise brand equity when customers willingly pay higher full prices; it can instead create more expensive inventory when aspiration outruns demand. Disclosure is currently insufficient to adjudicate that distinction directly.

Single-brand verdict. The strategy is working in running; it is unproven as a portfolio substitute. The best evidence is category-specific product success, not LI-NING 1990. The worst evidence is that consolidated growth has decelerated to low single digits while Anta's newer brands are still producing double-digit retail expansion.

Management has earned credit for the 2015 turnaround and for maintaining balance-sheet strength. Founder Li Ning's return coincided with the move from three consecutive annual losses back to profitability. Capital allocation is less clearly excellent. Selling equity at HK$87.50 in 2021 was highly advantageous for continuing shareholders in hindsight; holding almost RMB20bn of cash four years later while ROE falls toward 11% indicates that the company has yet to convert that capital into a comparably productive second engine.

Founder influence remains material. Viva Goods is a related substantial shareholder; Li Ning is deemed interested in shares held through Viva-related structures, and connected transactions between the groups are subject to Hong Kong Listing Rules disclosures. Viva Goods' own FY2025 reporting indicates its Li Ning position increased during the period. That alignment can promote long-term thinking, but ordinary shareholders should continue monitoring connected transactions and capital deployment rather than treating founder ownership as automatically positive.

The industry is no longer in the easy-penetration phase that characterised the 2000s. Sports participation, running, outdoor activities and health consciousness continue to create category growth, but the major Chinese brands now have extensive distribution and sophisticated digital operations. Public Euromonitor-derived reporting put Anta at about 23% of China's sportswear market in 2024/25, while other public market-share work placed Li Ning around 9% in 2023. I could not independently verify the 10.3% Li Ning market-share figure supplied in the brief from a primary or directly accessible Euromonitor dataset, so I exclude 10.3% from the factual base.

China sportswear combines a consumer cycle, an inventory cycle and a product-innovation cycle. The consumer cycle affects traffic and willingness to pay full price. The inventory cycle determines how quickly weaker sell-through becomes markdowns and wholesale-order cuts. The innovation cycle shifts share between brands even when total category demand is mediocre. This third cycle is why macro weakness alone is an inadequate explanation for Li Ning: Adidas has recovered in China through stronger local product, Anta's emerging brands remain fast-growing, and On and Hoka have taken advantage of running participation even while Nike struggles.

Geopolitics is secondary to domestic execution for current earnings. Li Ning's revenue remains overwhelmingly Mainland China, with other regions only 1.4% of FY2025 sales. That greatly limits direct tariff/export exposure, but it also means the company lacks geographic diversification. National-brand sentiment can periodically help domestic labels, as earlier cycles showed; investors should not capitalise political sentiment as a permanent moat. Products still have to win on function, design and value.

Horizontal competitor analysis

The relevant competitive set is larger than “Li Ning versus Anta.” Anta is the load-bearing comparison because both are Chinese groups with mass-market roots, but their answers to maturity have diverged so far that they now represent two different corporate strategies.

Li Ning chose concentration. It took a recognised national sports brand and tried to make that brand broader, more technical and more premium. The virtue is strategic coherence. R&D, athlete sponsorship, product storytelling, stores and digital traffic can all reinforce the same name. The liability is correlated failure: if the Li-Ning name loses relevance in basketball, fashion or a price tier, there is no unrelated major brand inside the listed group whose growth can offset the weakness.

Anta chose portfolio construction. FY2025 group revenue exceeded RMB80.2bn, up 13.3%; FILA generated RMB28.47bn and operating profit of RMB7.42bn. Its portfolio reaches mass-market performance through Anta, premium sports fashion through FILA, outdoor and specialist categories through other brands, and international premium sports through its controlling stake in Amer Sports. Amer itself grew FY2025 revenue 27%. In 2026 Anta added another option by agreeing to acquire a 29.06% stake in Puma for €1.5bn.

One numerical comparison captures the strategic gap:

† Public reporting of Anta's group margin includes a structurally different multi-brand mix and is not directly comparable to Li Ning's channel economics. ‡ Public operational update reporting; Xtep's core-brand Q2 deterioration resembles Li Ning more than Anta's portfolio result. Sources: company FY2025 results and 2026 operating updates.

The table explains why Anta deserves a structural valuation premium even before looking at a market multiple. Scale is 2.7 times Li Ning's. Growth is about four times faster. FILA alone is almost as large as Li Ning. Emerging brands supplied 25–30% retail growth in Q2 2026 at the same time Li Ning's system went negative.

The brief's stated 44.5% Anta interest in Amer Sports also appears stale. S&P Global described Anta as the controlling shareholder with an approximately 42% equity stake as of 2026-02-20. This does not change the qualitative house thesis; Amer remains a major Anta asset. But it is an example where fresh public work should supersede a sibling report or prompt assumption.

The attraction of Anta's model becomes strongest when one segment slows. In a mature consumer market, every brand eventually has a weak product cycle. A portfolio can redeploy capital and store relationships toward the brand with stronger momentum. Li Ning instead has to repair the same brand that is producing the slowdown. That makes its earnings more exposed to a single consumer-perception cycle.

The counterargument is capital discipline. Amer, Puma and a growing collection of brands create substantial integration, governance and valuation risks. Anta must prove it can allocate capital across businesses it did not create. Li Ning's almost RMB20bn liquidity position and absence of conventional borrowings make its balance sheet simpler and more transparent. At a sufficiently low price, concentration can be preferable to paying a high multiple for diversification.

Xtep is a useful domestic control group. FY2025 revenue from continuing operations rose 4.2% to RMB14.151bn, while its core Xtep brand grew only 1.5%. That makes Xtep's core-brand experience similar to Li Ning's: mature domestic labels are finding aggregate growth harder. Xtep's specialist running assets provide an additional route to growth, reinforcing the point that category specialisation is becoming more important than broad sporting-goods distribution.

Nike gives another control. It remains one of the world's deepest sports brands, but China has become a persistent weakness. Reuters reported repeated Greater China declines, pricing disorder, stale inventory and loss of share to Anta, Li Ning and specialist running brands. Nike's current US share price of US$41.70 carries a trailing P/E around 27.6 times as of 2026-08-07, well above Li Ning's roughly 11 times trailing earnings. The comparison warns against a simplistic “low P/E equals cheap” argument: Nike is being priced partly for a global turnaround and global brand assets; Li Ning is being priced as a China-concentrated franchise with low expected growth.

On Holding sits at the opposite end of the category life cycle. Its current equity value is approximately US$12bn, and it continues to be associated with premium running and high growth rather than mature mass-market sporting goods. On and Hoka's success in China, cited by industry participants in Reuters' China sportswear reporting, undermines the idea that Chinese consumers have stopped paying premium prices altogether. They are selective about where they pay them.

Adidas is particularly instructive. After severe China weakness, it returned to sustained growth by accelerating locally designed product; Reuters reported that localised product had risen to a large share of its Chinese assortment. This shows that brand age is not destiny. Mature franchises can regain share when product and channel execution improve. That is the bull template for Li Ning.

Anta comparison. The largest structural difference is now measurable rather than philosophical: Anta's portfolio contains several businesses whose growth can offset a weak core cycle, while Li Ning's strongest growth engines remain categories inside the same master brand. Q2 2026 is a live demonstration of the diversification advantage.

The ecological niche is therefore clear. Li Ning is China's large, technically credible, nationally resonant single-brand challenger. It sits above many commodity domestic labels in brand equity and product development, but below Anta in portfolio breadth and below Nike/Adidas in global scale. Its most defensible profit pool is Chinese performance sport, particularly running and basketball, rather than generic fashion. The companies most likely to take that pool are Anta's specialist brands, Adidas/Nike if their local execution improves, Xtep/Saucony in running, and newer premium-running labels.

A demand slowdown weakens Li Ning's niche more than Anta's because discounting across one master brand has a direct effect on the whole franchise. A running boom strengthens it because running is currently Li Ning's best product franchise. A broad price war weakens it because it cannot shift earnings toward a distinct luxury/outdoor brand whose customers are less price sensitive.

Peer valuation is the one part of the requested horizontal framework where I prefer an explicit limitation to false precision. I verified Li Ning's 2026-08-07 price and current trailing multiple, and Nike's current multiple through market-data tools, but I did not obtain equally dated, primary-quality 2026-08-07 closing-price/multiple observations for every Hong Kong peer before the research cutoff. I therefore do not print a spurious five-company “current P/E” table. The operating evidence is sufficient to conclude that Anta merits a premium to Li Ning; it is not sufficient here to claim that today's exact premium is X percentage points.

Current fundamentals, price attribution and valuation

The last twelve months contain two distinct halves.

H1 2025 revenue was RMB14.817bn, up 3.3%; net profit was about RMB1.74bn; gross margin was 50.0%; net margin was 11.7%. Those were the figures mistakenly identified as H1 2026 in the research brief. Full-year 2025 then ended with RMB29.598bn revenue, 49.0% gross margin and 9.9% net margin, which tells us H2 was weaker in profitability than H1.

Store productivity weakened as the year progressed. The H1 2025 presentation gave average monthly productivity of RMB300,000 for the directly operated store measure presented there; the FY2025 presentation reports approximately RMB284,000. The periods are not perfectly like-for-like, so I would not call that a formal same-store-sales decline. It is nevertheless consistent with the company's direct-retail revenue decline and increased promotion.

The 2026 sequence then moved from optimism to disappointment. Q1 main-brand retail sell-through grew by a mid-single digit. In Q2 it fell by a low-single digit overall, with franchise retail down a mid-single digit, direct retail down a low-single digit and online up a mid-single digit. The internet is keeping system sales from looking worse; the physical network is not presently growing.

That difference also helps separate real fundamentals from market narrative. “China consumer weakness” is real, but it cannot fully explain the Li Ning share price. Nike is weak in China, and Xtep's core brand has also slowed; that is the sector component. Anta/FILA remained positive and Anta's other brands grew 25–30%, while On/Hoka continue benefiting from premium running demand; that is the company/product component.

Price attribution. From approximately HK$18.66 at end-2025 to HK$14.54 on 2026-08-07, Li Ning has fallen about 22%. FY2025 EPS itself fell only 2.6%, so most of that price move cannot be a mechanical response to the audited earnings decline. The remaining fall represents some combination of lower expected 2026–2027 earnings and a lower multiple on those earnings. The Q2 reversal, discount concerns and broker target reductions in July are evidence for both. UOB Kay Hian explicitly described deeper discounting after Q2 and cut its target price; Daiwa and BOCI also reduced targets in July.

My interpretation is roughly two-thirds business/estimate deterioration and one-third pure sentiment/multiple de-rating, but that decomposition is an analytical estimate rather than a reported fact. The reason I put more weight on fundamentals is that the latest operating trend genuinely changed: Q1 grew; Q2 declined. The reason I still assign a meaningful multiple component is that a 22% equity-price drop is far larger than the change yet visible in reported annual EPS.

At HK$14.54, using FY2025 EPS of RMB1.1391 and the 2026-08-07 FX rate, the stock trades at approximately 11.0 times trailing earnings. The trailing earnings yield is therefore about 9.1%. The FY2025 dividend was RMB0.5695 per share, equal to about HK$0.662 at the same exchange rate, implying a trailing dividend yield around 4.6%.

The balance sheet makes the headline P/E unusually conservative in one sense. Converted at the stated FX rate, current market capitalisation is about RMB32.3bn, while cash and time deposits are almost RMB20.0bn. A mechanical ex-cash multiple would therefore look extremely low. I do not value the company by simply subtracting every renminbi of cash and applying a normal operating multiple: part of the cash is operational liquidity, part was raised for future expansion, and a company with falling ROE deserves a discount if it cannot deploy or return surplus capital efficiently.

Cash-flow passthrough nevertheless supports the valuation. Operating cash flow/net income was approximately 1.63x, 0.96x, 1.47x, 1.75x and 1.65x in 2021–2025; cumulatively OCF was about 1.47x cumulative net income. Treating all FY2025 capex as maintenance gives a deliberately conservative owner-cash proxy of RMB3.56bn, an approximately 11.0% yield on current equity value. That proxy is only about 21% above reported net profit, and lease cash requires additional economic adjustment, so the requested 30% divergence test is not met. Accounting earnings can therefore remain the main scenario anchor, with FCF used as a check.

My 12-month scenarios begin with FY2025 audited results and then ask what 2026 earnings and an appropriate market multiple look like after the Q2 deterioration. They are not consensus estimates.

† My three-year total-return calculation assumes approximately flat-to-declining earnings and a 10x terminal multiple in the conservative case, modest earnings recovery and about 13x in the base case, and high-single-digit earnings growth with about 16x in the optimistic case, plus scenario-consistent dividends. These are model outputs, not company guidance.

This is valuation-scenario analysis within a research framework, not investment advice.

The conservative scenario is not draconian. A 2% revenue decline and an 8–8.5% margin would still leave Li Ning highly profitable and liquid. It simply assumes Q2's weak physical retail trend persists and discounting prevents a fast margin rebound. An 11x multiple on roughly RMB0.93 EPS produces around HK$11.8 per share after FX conversion.

The base case assumes the current deterioration is a soft patch rather than the start of another structural inventory cycle. Revenue stays roughly flat to slightly positive, the net margin holds around 9%, and the market eventually assigns around 13x earnings once retail sell-through stabilises. That yields approximately HK$16 per share. The expected return from HK$14.54 is positive but not large enough to compensate a new investor for every downside path.

The optimistic case requires evidence that has not yet appeared: running continues to grow, basketball improves, Curry-related product becomes commercially meaningful, physical retail returns to growth, and premiumisation does not require increasing promotions. A roughly 10% margin and 15–16x multiple could justify around HK$23.

Historical valuation gives context for why I do not use the 2021 multiple as a normal benchmark. In 2021 Li Ning had 56% revenue growth, 136% profit growth, a 17.8% net margin and 26.9% ROE. The current business has 3.2% trailing revenue growth, declining profit, a 9.9% margin and 10.9% ROE. A permanent reset from a premium growth multiple to a low-teens consumer multiple is economically justified. The question is how low within that new regime.

Peer valuation supports a discount, but not an unlimited one. Anta's substantially better growth, portfolio optionality and Q2 momentum warrant a higher multiple. Nike's roughly 27.6x trailing P/E is not a sensible direct target for Li Ning because Nike has a much broader geographic revenue base and the market is capitalising a global turnaround. The relevant conclusion is that Li Ning should trade at a discount to businesses with stronger diversified growth until it demonstrates a second engine.

The expectation gap is now relatively low. At 11x trailing earnings, the stock no longer requires double-digit growth. The market appears to be pricing weak 2026 earnings and little near-term re-rating. The positive expectation gap would emerge if physical sell-through returns to positive territory while gross margin remains near 49%; the negative gap would emerge if falling sell-through starts producing inventory accumulation and a margin below 48%.

Margin of safety. The current HK$14.54 price is above the approximately HK$11.8 value in my conservative scenario, so there is zero margin of safety against that case under the prompt's definition. The most fragile base-case assumption is margin stabilisation: if the base 9% margin assumption were cut to 70%, roughly 6.3%, while keeping other assumptions unchanged, the equity value would fall toward approximately HK$11–12 rather than HK$16. The margin-of-safety sufficiency verdict is: none.

The flat-earnings test is less negative. With FY2025 earnings flat for three years, an unchanged exit multiple and the current approximately 50% payout, expected return would be dominated by a roughly 4½% annual dividend yield; a simple three-year calculation gives about 4.4% annualised before dividend reinvestment or FX movement. The Chinese 10-year government-bond yield was 1.7092% on 2026-08-07 according to CFETS. The flat-earnings return therefore exceeds the sovereign yield. Li Ning is not a “good company, bad price” case; it is closer to a “reasonable price, insufficient downside cushion” case.

The next major financial event should be the 2026 interim result. The company had not announced an exact board-meeting/result date as of 2026-08-08. Its prior-year interim result was released on 2025-08-21, so a working expectation of late August 2026 is reasonable, but this is an inference rather than an announced calendar date. That result will matter far more than another monthly share-price movement because it will finally reveal H1 2026 gross margin, net margin, working capital and cash flow.

Risks, catalysts, cross-synthesis and research conclusion

The first permanent-loss risk is prolonged discount-led demand weakness. I assign it medium-to-high probability and high impact. The observable indicators are gross margin below 48%, direct-store productivity below roughly RMB280,000 a month, falling new-product sell-through and physical retail remaining negative. FY2025 already contained greater direct-retail promotion and a 40-basis-point gross-margin decline; Q2 2026 then brought negative physical sell-through. The transmission path is straightforward: weaker traffic leads to promotions, promotions lower gross profit, lower gross profit collides with relatively fixed brand/R&D expenditure, earnings fall faster than sales and the market lowers the multiple because brand elevation has failed.

The second risk is single-brand share loss. Probability is medium; impact is high. Anta provides the observable benchmark. If Li Ning is flat or declining for several quarters while Anta's specialist brands continue growing double digits, the difference is unlikely to be explained by macro demand. The earnings effect would come through lower full-price sales and greater marketing cost; the valuation effect would be a permanent discount for lack of growth optionality.

The third risk is a return of channel stress. I assign medium probability but high impact because Li Ning's history shows how destructive it can be. Inventory days are currently stable at 64 and channel stock is around four months, so the risk has not materialised. The warning combination would be channel inventory above five months, inventory days above 75, receivables continuing to grow much faster than revenue and franchise sell-through staying negative. Wholesale revenue can initially look resilient while this develops; the eventual correction appears through shipment cuts, inventory provisions and deeper retail discounting.

The fourth risk is poor use of excess capital. Probability is medium and impact medium. Almost RMB20bn of cash and deposits protects downside but suppresses ROE when it earns low returns. A large acquisition at an unattractive price, related-party capital deployment or persistent cash accumulation without stronger dividends/buybacks would reduce the value investors should assign to each renminbi of cash. The 2021 equity issuance was brilliantly timed from the issuer's perspective, but future value depends on what that capital earns.

The fifth risk is currency translation. Operations and reporting are predominantly RMB while investors buy the HKD quote. Other regions are only 1.4% of sales, so operational transaction risk is small; the investor's HKD value of RMB earnings, dividends and cash changes with CNY/HKD. This is lower impact than brand and inventory risk but should not be silently ignored in valuation.

Positive catalysts are more concrete than they were a year ago. A return to positive franchise sell-through without wider discounts would immediately reduce inventory-cycle fears. Running can continue gaining share. Basketball could regain momentum through stronger signature products and the new Curry relationship. The cash balance allows a larger shareholder return without threatening solvency. The most important of these is the next interim statement, which could show that Q2's sell-through deterioration has not translated into a major gross-margin or inventory problem.

Negative catalysts are equally clear: an H1 gross margin below 48.5%, a full-year guidance reduction if management gives one, channel inventory above four months, another sequential deterioration in direct-retail productivity, or evidence that e-commerce growth is being bought through deeper markdowns. A continuing divergence in which Anta grows while Li Ning contracts would make the single-brand discount more structural.

A practical tracking dashboard follows. “Normal” means the range consistent with the current base case, not an industry law.

The baseline metrics come from FY2025/H1 2025 company disclosures and the latest Q2 2026 update; the thresholds are my monitoring rules.

Vertically, Li Ning has proved two capabilities over three decades. It can build a national sports brand with real product credibility, and it can repair a broken distribution system. The 2012 inventory collapse did not kill the franchise; founder-led restructuring returned it to profit by 2015 and eventually to exceptional profitability in 2021. Those are substantial achievements.

The company has not yet proved a third capability: generating durable growth after its core domestic brand reaches maturity. The 2021–2025 numbers are the cleanest evidence. Revenue rose from RMB22.6bn to RMB29.6bn, but earnings declined from RMB4.0bn to RMB2.94bn and ROE fell from 26.9% to 10.9%. That is not structural collapse; cash flow and balance sheet say otherwise. It is a shift from high-return growth into mature-brand economics.

The original success came from several sources. Founder identity was a genuine brand asset. China's rising incomes and rapid expansion of sporting-goods retail provided a large era tailwind. Franchising allowed the company to scale with less balance-sheet capital. The post-2015 turnaround added better digital execution and product creation. The 2019–2021 cycle then added unusually favourable domestic-brand sentiment and demand conditions. The mistake would be to attribute all of 2021's economics to timeless competitive advantage.

Some of those factors remain. The founder brand remains recognisable. Running technology is competitive. The distribution network is large. Online execution is keeping sales healthier than offline. Cash resources are stronger than at almost any prior point. The era tailwinds are weaker. China sportswear is a mature competitive market, and domestic ownership alone no longer differentiates Li Ning from Anta, Xtep and a growing field of localised foreign brands.

Horizontally, Anta shows what Li Ning lacks. The difference is not simply that Anta is bigger. FILA can be weak while Arc'teryx or another specialist label is strong; a slow Anta core can coexist with 25–30% growth in “other brands.” Li Ning's running category can offset basketball weakness to a degree, but both remain under the same consumer brand and distribution architecture. Category diversification is weaker than brand diversification when the master brand itself loses pricing power.

Li Ning's corresponding advantage is simplicity. There is no need to underwrite a €1.5bn Puma stake, a global M&A integration programme or a large portfolio of brand-management teams. A highly focused Li Ning could potentially earn good returns by becoming the best Chinese performance-running and basketball franchise rather than recreating Anta. The investment case would improve if management proves that focus generates superior store productivity and margins. Current data do not prove it.

What is the market most likely misjudging? I think investors are correctly sceptical about growth but may be underweighting balance-sheet and cash-flow protection. A roughly 11x trailing P/E on a company with almost RMB20bn of cash/deposits and FY2025 OCF of RMB4.85bn is not an expensive starting valuation. The market is less likely to be wrong about the operating slowdown: Q2 physical retail data validate that concern.

The 12-month variable is retail sell-through plus gross margin. A weak top line is survivable if inventory stays clean and gross margin remains around 49%; it becomes a different investment case if discounting takes gross margin toward 46–47%. The three-year variable is whether Li Ning can turn running success into a broader portfolio of profitable sports categories without diluting the brand. The five-year variable is whether management can turn almost RMB20bn of liquidity into either a second growth engine or materially greater per-share cash returns.

The stock becomes a better investment under one of two combinations. The operating route is positive: franchise and direct sell-through recover, gross margin holds above 49%, running stays double-digit and basketball returns to growth. That would justify a higher base multiple even at a moderately higher share price. The valuation route is negative but investable: operations stay mediocre, yet the shares fall to around HK$9–9.5 while inventory, cash flow and balance-sheet health remain intact. At that point the conservative scenario would itself carry a meaningful margin of safety.

The original judgment should be overturned negatively if channel inventory exceeds five months, gross margin falls below 48% for two consecutive reporting periods, direct-store productivity stays below approximately RMB280,000 while promotions deepen, or net cash begins falling materially without either growth or shareholder distributions. It should be overturned positively if physical sell-through returns to mid-single-digit growth, basketball/running together generate sustainable category growth and premium-line economics become sufficiently disclosed to prove full-price demand.

The bull case can be reduced to four traceable facts:

• FY2025 operating cash flow of RMB4.85bn substantially exceeded RMB2.94bn net income, while cash and deposits approached RMB20bn and conventional borrowings were nil in the headline financial summary.
• Running has become roughly 31% of retail sell-through and grew about 10% in FY2025, showing that Li Ning can still create category-level product momentum.
• Inventory turnover stayed at 64 days and management reported four months of channel stock despite the weak consumer environment, far from a confirmed 2012-style inventory breakdown.
• At HK$14.54 the stock trades around 11x trailing earnings and roughly an 11% FY2025 OCF-minus-capex yield, meaning little high growth is embedded in the price.

The bear case is equally concrete:

• Q2 2026 total retail sell-through went from Q1 mid-single-digit growth to a low-single-digit decline, with franchise sell-through down a mid-single digit.
• FY2021–FY2025 revenue compounded around 7%, but net profit compounded down about 7.5%, with net margin falling from 17.8% to 9.9% and ROE from 26.9% to 10.9%.
• Anta generated more than RMB80bn of FY2025 revenue and its emerging brands grew 25–30% at retail in Q2 2026, showing that Li Ning's weakness cannot be blamed entirely on Chinese consumer demand.
• Li Ning does not separately disclose LI-NING 1990 revenue, ASP, margin or store returns, so the premiumisation strategy at the heart of its single-brand response cannot be independently proven from public accounts.
• Trade receivables rose about 38% in FY2025 against 3.2% revenue growth, making distributor cash conversion a necessary next-report check even though reported receivable days remain low.

The pre-mortem has two plausible scripts.

In the first, Anta's specialist brands and Adidas' localised products continue taking incremental consumer attention through 2027 while Li Ning's basketball line fails to recover. Franchise sell-through remains down 5–8%, Li Ning clears stock through online and direct-store discounting, gross margin falls from 49% to about 45%, net margin reaches 6–7%, and the market applies 8x earnings instead of 11–13x. With earnings around RMB0.7–0.8 per share, the stock could trade near HK$7–8, approximately half today's level.

In the second, reported inventory stays acceptable for several quarters because distributors absorb more stock, but receivables and channel inventory eventually reveal that sell-in outran consumer demand. By 2027 channel inventory exceeds five months, direct productivity drops below RMB260,000 per month and the company funds a major clearance programme. Even without solvency risk, a return to an 8x distressed-consumer multiple on RMB0.7–0.9 EPS could again produce a HK$7–9 share price. This is a milder version of the transmission mechanism seen in 2012, not a prediction that the same crisis will recur.

Investment rating. Li Ning today is a financially strong company with a weakening operating signal. The current valuation already recognises a large part of the growth slowdown, but the latest Q2 data do not justify treating the low multiple as obvious mispricing. Anta's performance is the decisive cross-check: the consumer environment is difficult, yet a more diversified competitor is still finding growth. That makes some of Li Ning's deterioration company-specific.

I would hold an existing position at HK$14.54 because the cash-rich balance sheet, high cash conversion and 4%+ dividend yield provide real protection, while the current price lies inside my base-case acceptable-hold band. I would not initiate a full-value position here because the conservative case is below the market price. The shares become significantly more interesting around HK$9–9.5 if inventory and cash remain healthy, or at a higher price only after physical sell-through and margins visibly turn.

【Company-profile scores】

• Fundamental quality: medium
• Growth: low
• Moat: medium
• Financial soundness: strong
• Management credibility: medium
• Valuation attractiveness: medium
• Risk level: medium
• Suitable investor type: value / cyclical

【Investment rating】

• Rating: Hold
• One-line thesis: Cash-rich and cheap on trailing earnings, but Q2 sell-through deterioration and single-brand concentration cap re-rating until retail productivity and margins stabilise.
• Ideal buy price:

【Ideal Buy Price】8.5–9.4 HKD Basis: a 20–28% margin of safety below the approximately HK$11.8 conservative-case value, provided channel inventory remains around four months and gross margin stays above 48%.

• Acceptable hold price: HK$13.6–18.4, corresponding to approximately ±15% around the HK$16 base-case fair value.
• Clearly overvalued price: HK$25.3 and above, at least 10% above the approximately HK$23 optimistic-case value.
• Current-price classification: acceptable hold.
• Whether to wait for a better price: yes. For a new position, the preferred trigger is HK$8.5–9.4 with inventory and cash metrics intact; the opportunity cost is missing a re-rating if H1/H2 results prove Q2 was temporary.
• Target holding horizon: 3–5 years; the 12-month view is primarily a test of sell-through and margin stabilisation.
• Expected annualized return: conservative about −7%; base about +10–12%; optimistic about +25–29% over a three-year scenario horizon, including estimated dividends.
• Max-loss risk: approximately 50–55% in a severe channel/discounting scenario that drives net margin toward 6–7% and the valuation to about 8x earnings.
• Reassessment-trigger signals: gross margin below 48% for two consecutive reporting periods; channel inventory above five months; inventory turnover above 75 days; direct-store productivity below RMB280,000 with deeper promotions; or franchise sell-through below −5% for two quarters.

【Valuation Range】

• current: 14.54 (close as of 2026-08-07)
• bear (conservative · ideal buy zone): [8.5, 9.4]
• base (fair · acceptable hold zone): [13.6, 18.4]
• bull (optimistic · above the clearly-overvalued line): [25.3, 28.0]

The margin-of-safety verdict remains none at the current price because HK$14.54 sits above the conservative fair value even though it lies inside the base hold range. “Hold” therefore means the expected-value balance is adequate for an existing owner, not that today's quote is an ideal new-money entry.

Sources and uncertainties. The primary source spine is Li Ning's FY2025 audited results and financial highlights, the company's FY2025 presentation, the 2026 Q2 operational update, FY2024/FY2023 company results and the 2021 audited annual report. Historical capital-market events use HKEX records and Reuters/Dow Jones reporting; peer analysis relies primarily on company results and current operating updates.

Four uncertainties materially constrain the analysis. First, no H1 2026 financial statements existed in the official disclosure record at the 2026-08-08 research cutoff, so current margin, inventory and cash-flow estimates remain modelled rather than reported. Second, LI-NING 1990 economics are aggregated with the main brand, preventing independent verification of the premiumisation strategy. Third, Li Ning does not disclose channel-level gross margins or a complete direct-versus-franchise comparable-store-sales series, so discounting has to be triangulated through gross margin, sell-through, store productivity and inventory. Fourth, the in-house reports identified in the research brief were not supplied as accessible source documents in this research session; I therefore used current public filings rather than assuming their financial or valuation inputs. The most material identifiable contradiction with the prompt is Anta's Amer Sports stake: current public information puts it around 42%, rather than 44.5%.

Other tickers mentioned

• 2020.HK — Anta Sports is the load-bearing comparison because its multi-brand model is the clearest alternative to Li Ning's single-brand strategy.
• 1368.HK — Xtep is a domestic control case whose mature core brand is also experiencing slower growth.
• AS.US — Amer Sports provides Anta with exposure to Arc'teryx, Salomon and Wilson and grew revenue 27% in FY2025.
• NKE.US — Nike illustrates that China sportswear weakness is partly sector-wide, while also showing the consequences of inventory and pricing disorder.
• ONON.US — On is a premium-running challenger whose China growth shows consumers will still pay for differentiated performance product.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.